
https://www.science.org/content/blog-post/max-gergel-s-second-odd-book
# Article Title (February 2012)

## 1. SUMMARY

The article is a book review of Max Gergel's second memoir, "The Ageless Gergel," which the author describes as even more rambling and disorganized than Gergel's first book. The review focuses primarily on an anecdote from the book about isovaleric acid and its acid chloride derivative. Gergel recounts how his company, Columbia Organic Chemicals, took on a contract to produce isovaleroyl chloride after another company (Hardwicke Chemical) wanted to offload this undesirable manufacturing job. The substance was described as having an extremely foul, persistent odor (reminiscent of rancid butter, goat, and old sneakers) that was resistant to soap, water, and cleaning agents. Beyond this anecdote, the review notes the book is poorly structured, filled with less compelling stories than the first volume, and concludes abruptly.

## 2. HISTORY

The critical aspect of this article—the chemical, isovaleroyl chloride, and its connection to human disease—had already been extensively studied and documented long before 2012. Isovaleric acidemia is a well-known inherited metabolic disorder (OMIM #243500), first described in 1966, resulting from a deficiency of isovalerate-CoA dehydrogenase. This leads to the accumulation of isovaleric acid and its derivatives, producing the characteristic odor that Gergel vividly described. Throughout the decades prior to 2012, significant progress had been made in understanding, diagnosing, and managing this condition. Newborn screening programs had been developed to identify affected infants early. By 2012, management strategies, including dietary modifications and L-carnitine supplementation, were already established. The article is reviewing a memoir that is anecdotally describing a chemical in an industrial context. The main "development" after 2012 is the continuing refinement of medical management for the genetic disease associated with the chemical Gergel's company found so unpleasant. However, there were no new, groundbreaking discoveries about isovaleric acid/acidemia triggered by this article; it was simply a nostalgic look at historical chemical manufacturing. The article did not lead to any FDA-approved drugs, substantial public policy changes, or any notable business impacts.

## 3. PREDICTIONS

The article itself does not make any specific, testable predictions about the future of biotechnology, chemistry, or medicine. It's a retrospective book review.

## 4. INTEREST

Rating: **2/10**
While the Max Gergel memoirs provide interesting historical anecdotes about the chemical industry and Max Gergel himself was a notable figure in custom chemical manufacturing, this specific blog post is primarily a review of a "rambling and formless" lesser-known second book. The article's focus on an obscure anecdote about a foul-smelling chemical, while mildly interesting, lacks significant scientific, historical, or literary merit and has no tangible connection to broader developments in biotechnology or medicine beyond the already established connection to isovaleric acidemia, which was well-known long before 2012. The article's primary purpose seems to be commentary on a niche historical document rather than providing a deep scientific discussion, so its relevance to major advancements is very limited.


----
_model_params = {'model': 'nex-agi/deepseek-v3.1-nex-n1:free', 'input': '20120222-max-gergel-s-second-odd-book.txt', 'reasoning': {'effort': 'high'}, 'text': {'verbosity': 'medium'}, 'prompt-template': 'prompt-template-2'}_